1. Home
  2. CARM vs YCBD Comparison

CARM vs YCBD Comparison

Compare CARM & YCBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CARM
  • YCBD
  • Stock Information
  • Founded
  • CARM 2016
  • YCBD 2015
  • Country
  • CARM United States
  • YCBD United States
  • Employees
  • CARM N/A
  • YCBD N/A
  • Industry
  • CARM Biotechnology: Pharmaceutical Preparations
  • YCBD Biotechnology: Pharmaceutical Preparations
  • Sector
  • CARM Health Care
  • YCBD Health Care
  • Exchange
  • CARM Nasdaq
  • YCBD Nasdaq
  • Market Cap
  • CARM 8.4M
  • YCBD 7.8M
  • IPO Year
  • CARM N/A
  • YCBD N/A
  • Fundamental
  • Price
  • CARM $0.41
  • YCBD $0.86
  • Analyst Decision
  • CARM Hold
  • YCBD Strong Buy
  • Analyst Count
  • CARM 5
  • YCBD 1
  • Target Price
  • CARM $0.90
  • YCBD $3.00
  • AVG Volume (30 Days)
  • CARM 42.2M
  • YCBD 81.7K
  • Earning Date
  • CARM 08-07-2025
  • YCBD 08-08-2025
  • Dividend Yield
  • CARM N/A
  • YCBD N/A
  • EPS Growth
  • CARM N/A
  • YCBD N/A
  • EPS
  • CARM N/A
  • YCBD N/A
  • Revenue
  • CARM $19,964,000.00
  • YCBD $19,593,146.00
  • Revenue This Year
  • CARM N/A
  • YCBD $13.00
  • Revenue Next Year
  • CARM N/A
  • YCBD $10.00
  • P/E Ratio
  • CARM N/A
  • YCBD N/A
  • Revenue Growth
  • CARM 32.45
  • YCBD N/A
  • 52 Week Low
  • CARM $0.14
  • YCBD $0.76
  • 52 Week High
  • CARM $1.42
  • YCBD $6.54
  • Technical
  • Relative Strength Index (RSI)
  • CARM 51.65
  • YCBD 40.85
  • Support Level
  • CARM $0.37
  • YCBD $0.84
  • Resistance Level
  • CARM $0.44
  • YCBD $1.00
  • Average True Range (ATR)
  • CARM 0.07
  • YCBD 0.08
  • MACD
  • CARM -0.01
  • YCBD 0.02
  • Stochastic Oscillator
  • CARM 10.37
  • YCBD 26.32

About CARM Carisma Therapeutics Inc.

CARISMA Therapeutics Inc is a clinical-stage cell therapy company focused on utilizing Carisma's proprietary chimeric antigen receptor macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. The company has created a comprehensive cell therapy platform to enable the therapeutic use of engineered macrophages and monocytes, which belong to a subgroup of white blood cells called myeloid cells.

About YCBD cbdMD Inc.

cbdMD Inc is a United States based company. It owns and operates the consumer hemp-based cannabidiol (CBD) brand, cbdMD, Paw CBD as well as ATRx Labs brand of functional mushrooms. The company's product categories include CBD tinctures, CBD gummies, CBD topicals, CBD capsules, CBD oils, and CBD pet products. The firm distributes its products through an e-commerce website, wholesalers, and a variety of brick-and-mortar retailers.

Share on Social Networks: